Health Minister Dr. Sudha Sharma Gautam Visits Indian Pharmacopoeia Commission for Technical Collaboration
Nepal India Health Diplomacy
17th December 2025, Kathmandu
Health and Population Minister Dr. Sudha Gautam recently visited the Indian Pharmacopoeia Commission (IPC) in New Delhi.
Nepal India Health Diplomacy
This high-level visit took place while the Minister was in India to participate in the second WHO Global Summit on Traditional Medicine.
This crucial interaction is expected to significantly bolster the ties between the two nations’ health sectors, focusing intensely on advancements in health technology and regulatory structure.
This visit underscores the importance of Nepal India Health Diplomacy and sets the stage for vital technical collaboration to uplift Nepal’s pharmaceutical sector.
Inside the IPC: A Look at State-of-the-Art Facilities
During her visit, Minister Gautam inspected the IPC’s state-of-the-art laboratories. IPC maintains cutting-edge facilities that ensure the quality and standardization of medicines.
The Minister thoroughly examined the advanced instruments and complex testing procedures used by the Commission. She actively engaged with senior IPC officials, seeking insights into India’s robust drug regulatory structure and operational procedures.
The Need for Enhanced Technical Collaboration
A major focus of the discussion was identifying specific areas for technical collaboration. Nepal is actively working to upgrade its Department of Drug Administration (DDA).
The goal is to achieve Maturity Level 3 of international standards for drug regulation. Attaining this level requires substantial technological and procedural enhancements.
National Drug Laboratory: A Push for ‘State of the Art’
To meet the stringent international requirements, Nepal’s National Drug Laboratory (NDL) must transform into a ‘state-of-the-art’ facility. This transformation demands significant resources, expertise, and guidance.
Advertisement
Minister Gautam sought practical assistance from the IPC to realize this crucial upgrade. The discussion centered on transferring knowledge, training personnel, and providing technical support for laboratory development.
India’s Role in Uplifting Nepal’s Pharmaceutical Sector
India plays a pivotal role in the global pharmaceutical sector. Its regulatory experience is invaluable. IPC’s support is seen as essential for boosting the efficiency and credibility of Nepal’s drug regulatory system.
Improved quality control and regulatory oversight are critical. These steps will ensure that Nepalese consumers have access to safe, high-quality, and effective medicines.
Furthermore, the enhanced system will open new avenues for the Nepalese pharmaceutical sector on the international stage.
A Diplomatic Move for Better Public Health
Minister Gautam’s proactive engagement highlights the government’s commitment to improving public health standards. The discussions clearly emphasized strengthening the existing Nepal India Health Diplomacy.
Both sides recognized the mutual benefits of a stable, technologically advanced pharmaceutical sector across the region.
Officials from both countries acknowledged that shared expertise and collaborative efforts are the most effective path forward.
The visit concluded with a strong sense of optimism about the future of drug regulation in Nepal, underpinned by India’s technical expertise.
This proactive step ensures better health outcomes for the Nepali population. The formalizing of technical collaboration efforts remains a top priority.
For more: Nepal India Health Diplomacy
